1Doshi SK,Singh BN.Pure class Ⅲ antiarrhythmic drugs:focus on dofetilide[J].Cardiovasc Pharmacol Ther,2000,5(4):237-247.
2Varriale PV,Sedighi A.Acute management of atrial fibrillation and atrial flutter in the critical care unit:Should it be ibutilide[J]?Clin Cardiol,2000,23:265-268.
3Hongo RH,Themistoclakis S,Raviele A,et al.Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents[J].Am Coll Cardiol,2004,44(4):864-868.
5Khan A.Pharmacological cardioversion of recent onset atrial fibrillation[J].Eur Heart J,2004,25(15):1274-1276.
6Li HT,Wang YQ,Dai DZ,et al.Frequency dependent prolongation of effective refractory period by a complex class Ⅲ antiarrhythmic agent[J].Acta Pharmacol Sin,2001,22(1):32-36.
7Miller MR,McNamara RL,Segal JB,et al.Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm:a meta analysis of clinical trials[J].Fam Pract,2000,49:1033-1046.
8Cheng J,Glatter K,Yang Y,et al.Electrophysiological response of the right atrium to ibutilide during typical atrial flutter[J].Circulation,2002,106(7):814-819.
10Cheng J,Glatter K,Yang Y,et al.Electrophysiological response of the right atrium to ibutilide during typical atrial flutter[J].Circulation,2002,106(7):814-819.
